Osiris stem cell platform success hinges on 2 trials
(Reuters)
Unusual Little Blurbs
Reuters - Osiris Therapeutics Inc, which is developing a drug to treat a rare condition that affects bone marrow transplant patients, is poised to unveil results from a late-stage trial that could pave the way for the first approved drug in that indication and instill investor confidence in the company.
Source: Yahoo! News: Biotechnology News